Plans to expand releases of GM mosquitoes in the Cayman Islands in 2017 raise important questions about cost-effectiveness, scientific protocols, risk assessment and public consent. […]
|
||||||
|
A study has examined the potential intended and unintended impacts of the mass release of GM insects on organic farmers, finding that this is likely to impose uncertainty on individual farmers and the agricultural industry as a whole. […] This review discusses the factors that should be considered in the assessment of the risks of GM plants to soil microorganisms, the limitations of current research methods, and the prospects for better biosafety assessment. […] GE mosquito company Oxitec has admitted a major risk of its technology – reducing one mosquito species may increase the numbers of a second disease-carrying species. […] More than 270,000 people have raised concerns over the US FDA’s review of Oxitec’s planned release of genetically engineered mosquitoes in Florida. […] This article, written by an entomologist and mosquito vector control expert, argues why genetic modification of mosquitoes is no answer to mosquito-borne diseases. […] This report explains why the proposed field release of GM diamondback moths in New York is fraught with flaws, risks, missing safeguards and insufficient regulation. […] GeneWatch UK briefing summarizing the concerns related to GM mosquitoes. […] This report warns that GM insect factories could spread antibiotic resistant bacteria into the environment, posing a risk to human health. […] Recent research from Panama raises questions on the strategy of releasing GM Aedes aegypti mosquitoes in a bid to control dengue, given the close similarities it has with another mosquito species, Aedes albopictus. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||